EMEA-000120-PIP01-07-M05
Key facts
| Invented name |
Tygacil
|
| Active substance |
Tigecycline
|
| Therapeutic area |
Other
|
| Decision number |
P/0292/2014
|
| PIP number |
EMEA-000120-PIP01-07-M05
|
| Pharmaceutical form(s) |
Powder for solution for infusion
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
Pfizer Limited
E-mail: pip_enquiries@pfizer.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000120-PIP01-07-M05
|
| Compliance opinion date |
12/12/2014
|
| Compliance outcome |
positive
|